Avalo Therapeutics (AVTX) Shares Issued (2014 - 2026)

Avalo Therapeutics (AVTX) has 12 years of Shares Issued data on file, last reported at $2.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued changed N/A year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (down 93.64% YoY), and the FY2025 full-year result was $23000.0, down 99.98% from the prior year.
• Shares Issued for Q1 2026 stood at $2.2 million, up from $23000.0 in the prior quarter.
• Across five years, Shares Issued topped out at $142.7 million in Q4 2024 and bottomed at -$108.1 million in Q2 2024.
• The 5-year median for Shares Issued is $1.1 million (2023), against an average of $16.3 million.
• Peak annual rise in Shares Issued reached 662.2% in 2024, while the deepest fall reached 161443.28% in 2024.
• A 5-year view of Shares Issued shows it stood at -$14.8 million in 2022, then soared by 226.24% to $18.7 million in 2023, then jumped by 662.2% to $142.7 million in 2024, then slumped by 99.98% to $23000.0 in 2025, then jumped by 9369.57% to $2.2 million in 2026.
• The last three Shares Issued figures came in at $2.2 million (Q1 2026), $23000.0 (Q4 2025), and $142.7 million (Q4 2024), per Business Quant data.

Peer Comparison